Edition:
United States

Intra-Cellular Therapies Inc (ITCI.OQ)

ITCI.OQ on NASDAQ Stock Exchange Global Select Market

19.97USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$19.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
156,469
52-wk High
$22.65
52-wk Low
$7.85

Select another date:

Mon, Nov 20 2017

BRIEF-Intra-Cellular Therapies receives FDA fast track designation for Schizophrenia treatment drug

* Intra-Cellular Therapies receives FDA fast track designation for lumateperone for the treatment of schizophrenia

BRIEF-Intra-Cellular starts enrollment in ITI-214 clinical trial in patients with Parkinson’s disease

* Intra-Cellular therapies announces commencement of enrollment of a clinical trial evaluating ITI-214 in patients with Parkinson’s disease Source text for Eikon: Further company coverage:

BRIEF-Intra-Cellular announces proposed public offering of common stock

* Intra-Cellular Therapies announces proposed public offering of common stock

BRIEF-BB Biotech reports 5.1 pct passive stake in Intra-Cellular Therapies

* BB Biotech AG reports 5.1 percent passive stake in Intra-Cellular Therapies Inc as of August 18, 2017 - SEC filing‍​ Source text: (http://bit.ly/2xcLrz4) Further company coverage:

Select another date: